ADM Bioscienceis the first in the world to develop PDRN micro needle patches.
ADM Bioscience’s micro needle patches combine polydeoxyribonucleotide (PDRN) with an excellent safety profile and strong efficacy of tissue regeneration of the skin and cartilage, and anti-inflammatory qualities, while specializing in mass-production techniques secured through trial and error grounded in ideas obtained from careful consideration and rigorous analysis. This synergy represents a revolutionary product in the field of transdermal drug delivery system (TDDS).
We pledge to deliver products that are safe, effective and convenient to administer that everyone can rely on through incessant R&D and innovation.
CEO Jung Byung-chul